Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522 Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Squamous Cell
  • Chemoradiotherapy
  • Head and Neck Neoplasms

abstract

  • Adding cetuximab to radiation-cisplatin did not improve outcome and hence should not be prescribed routinely. PFS and OS were higher in patients with p16-positive OPC, but outcomes did not differ by EGFR expression.

publication date

  • September 20, 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4162493

Digital Object Identifier (DOI)

  • 10.1200/JCO.2013.53.5633

PubMed ID

  • 25154822

Additional Document Info

start page

  • 2940

end page

  • 50

volume

  • 32

number

  • 27